Transition metal abnormalities in progressive dementias
- 12 November 2011
- journal article
- Published by Springer Nature in BioMetals
- Vol. 25 (2) , 337-350
Abstract
Abnormal distributions of transition metals inside the brain are potential diagnostic markers for several central nervous system diseases, including Alzheimer’s disease (AD), Parkinson’s disease, dementia with Lewy bodies (DLB), bipolar disorders and depression. To further explore this possibility, the total concentrations of iron, zinc, copper, manganese, aluminum, chromium and cadmium were measured in post-mortem hippocampus and amygdala tissues taken from AD, DLB and Control patients. A statistically significant near fifty percent reduction in the total copper levels of AD patients was observed in both the hippocampus and amygdala. The statistical power of the hippocampus and amygdala copper analysis was found to be 86 and 74% respectively. No statistically significant deviations in the total metal concentrations were found for zinc, manganese, chromium or aluminum. Iron was found to be increased by 38% in AD amygdala tissues, but was unchanged in AD hippocampus tissues. Accounting for differences in tissue water content, as a function of both tissue type and disease state, revealed more consistencies with previous literature. To aid in the design of future experiments, the effect sizes for all tissue types and metals studied are also presented.Keywords
This publication has 35 references indexed in Scilit:
- Copper toxicity in the general populationClinical Neurophysiology, 2010
- Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluidNeurobiology of Aging, 2009
- Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylationProceedings of the National Academy of Sciences, 2009
- Longitudinal prognostic value of serum “free” copper in patients with Alzheimer diseaseNeurology, 2009
- A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's diseaseBiochemical Society Transactions, 2007
- Prevalence of haemochromatosis gene mutations in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Copper neurotoxicity is dependent on dopamine‐mediated copper uptake and one‐electron reduction of aminochrome in a rat substantia nigra neuronal cell lineJournal of Neurochemistry, 2001
- The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)Science, 1996
- Al, Zn, Cu, Mn and Fe levels in brain in Alzheimer's diseaseArchives of Gerontology and Geriatrics, 1995
- Neutron activation analysis techniques for identifying elemental status in Alzheimer's diseaseJournal of Radioanalytical and Nuclear Chemistry, 1987